5521. Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis. Issue 2 (29th May 2013) Authors: Hoofnagle, J. H.; Van, M. L.; Kleiner, D. E.; Clark, J. M.; Kowdley, K. V.; Loomba, R.; Neuschwander‐Tetri, B. A.; Sanyal, A. J.; Tonascia, J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 38:Issue 2(2013) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5522. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer. Issue 8 (3rd March 2019) Authors: Bond, Ashley; Greenwood, Rosemary; Lewis, Stephen; Corfe, Bernard; Sarkar, Sanchoy; O'Toole, Paul; Rooney, Paul; Burkitt, Michael; Hold, Georgina; Probert, Chris Journal: Alimentary pharmacology & therapeutics Issue: Volume 49:Issue 8(2019) Page Start: 1005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5523. Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach. Issue 1 (2nd May 2016) Authors: Baranska, A.; Mujagic, Z.; Smolinska, A.; Dallinga, J. W.; Jonkers, D. M. A. E.; Tigchelaar, E. F.; Dekens, J.; Zhernakova, A.; Ludwig, T.; Masclee, A. A. M.; Wijmenga, C.; van Schooten, F. J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 1(2016) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5524. Volatile organic compounds in breath can serve as a non‐invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer. Issue 3 (20th December 2019) Authors: van Keulen, Kelly E.; Jansen, Maud E.; Schrauwen, Ruud W. M.; Kolkman, Jeroen J.; Siersema, Peter D. Journal: Alimentary pharmacology & therapeutics Issue: Volume 51:Issue 3(2020) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5525. Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Issue 3 (5th December 2013) Authors: Maieron, A.; Salzl, P.; Peck‐Radosavljevic, M.; Trauner, M.; Hametner, S.; Schöfl, R.; Ferenci, P.; Ferlitsch, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 3(2014) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5526. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Issue 7 (29th January 2018) Authors: Mandorfer, M.; Schwabl, P.; Paternostro, R.; Pomej, K.; Bauer, D.; Thaler, J.; Ay, C.; Quehenberger, P.; Fritzer‐Szekeres, M.; Peck‐Radosavljevic, M.; Trauner, M.; Reiberger, T.; Ferlitsch, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 7(2018) Page Start: 980 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5527. Vonoprazan prevents bleeding from endoscopic submucosal dissection‐induced gastric ulcers. Issue 6 (28th July 2016) Authors: Kagawa, T.; Iwamuro, M.; Ishikawa, S.; Ishida, M.; Kuraoka, S.; Sasaki, K.; Sakakihara, I.; Izumikawa, K.; Yamamoto, K.; Takahashi, S.; Tanaka, S.; Matsuura, M.; Hasui, T.; Wato, M.; Inaba, T. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 6(2016) Page Start: 583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5528. Weekend hospitalisations and post‐operative complications following urgent surgery for ulcerative colitis and Crohn's disease. Issue 9 (4th March 2013) Authors: Ananthakrishnan, A. N.; McGinley, E. L. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 9(2013) Page Start: 895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5529. Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Issue 10 (15th February 2022) Authors: Goodoory, Vivek C.; Ng, Cho Ee; Black, Christopher J.; Ford, Alexander C. Journal: Alimentary pharmacology & therapeutics Issue: Volume 55:Issue 10(2022) Page Start: 1311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5530. Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis. Issue 3 (9th October 2021) Authors: Rubin, David T.; Modesto, Irene; Vermeire, Séverine; Danese, Silvio; Ng, Siew C.; Kwok, Kenneth K.; Koram, Nana; Jones, Thomas V. Journal: Alimentary pharmacology & therapeutics Issue: Volume 55:Issue 3(2022) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗